{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T11:23:49Z","timestamp":1790940229895,"version":"4.1.0"},"reference-count":80,"publisher":"American Society for Microbiology","issue":"2","license":[{"start":{"date-parts":[[2003,1,15]],"date-time":"2003-01-15T00:00:00Z","timestamp":1042588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Virol"],"published-print":{"date-parts":[[2003,1,15]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>The group C adenoviruses typically cause acute respiratory disease in young children. In addition, a persistent phase of infection has been observed in which virus may be shed for years without producing overt pathology. Our laboratory recently reported that group C adenovirus DNA can be found in tonsil and adenoid T lymphocytes from the majority of pediatric donors (C. T. Garnett, D. Erdman, W. Xu, and L. R. Gooding, J. Virol. 76:10608-10616, 2002). This finding suggests that immune evasion strategies of human adenoviruses may be directed, in part, toward protection of persistently or latently infected T lymphocytes. Many of the adenoviral gene products implicated in prevention of immune destruction of virus-infected cells are encoded within the E3 transcription unit. In this study, the E3 promoter was evaluated for sensitivity to T-cell activation signals by using a promoter reporter plasmid. Indeed, this promoter is extremely sensitive to T-cell activation, with phorbol myristate acetate (PMA) plus ionomycin increasing E3-directed transcription 100-fold. By comparison, in the same cells E1A expression leads to a 5.5-fold increase in transcription from the E3 promoter. In contrast to induction by E1A, activation by PMA plus ionomycin requires the two E3 NF-\u03baB binding sites. Interestingly, expression of E1A inhibits induction of the E3 promoter in response to T-cell activation while increasing E3 promoter activity in unactivated cells. Collectively, these data suggest that the E3 promoter may have evolved the capacity to respond to T-cell activation in the absence of E1A expression and may act to upregulate antiapoptotic gene expression in order to promote survival of persistently infected T lymphocytes.<\/jats:p>","DOI":"10.1128\/jvi.77.2.1112-1119.2003","type":"journal-article","created":{"date-parts":[[2002,12,26]],"date-time":"2002-12-26T19:42:51Z","timestamp":1040931771000},"page":"1112-1119","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":19,"title":["The Adenovirus E3 Promoter Is Sensitive to Activation Signals in Human T Cells"],"prefix":"10.1128","volume":"77","author":[{"given":"Jeffrey A.","family":"Mahr","sequence":"first","affiliation":[{"name":"Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia 30322"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy M.","family":"Boss","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia 30322"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda R.","family":"Gooding","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia 30322"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.167.6.3164"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1385\/IR:23:2-3:157"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M008218200"},{"key":"e_1_3_2_5_2","doi-asserted-by":"crossref","first-page":"5049","DOI":"10.4049\/jimmunol.162.9.5049","volume":"162","year":"1999","unstructured":"Bennett, E. M., J. R. Bennink, J. W. Yewdell, and F. M. Brodsky. 1999. Cutting edge: adenovirus E19 has two mechanisms for affecting class I MHC expression. J. Immunol. 162 : 5049-5052.","journal-title":"J. Immunol."},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.ge.20.120186.000401"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1165\/ajrcmb.17.1.f132"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/22.15.3053"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/312608a0"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a121094"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)80552-8"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.19.3.2098"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.75.20.9844-9856.2001"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.19.10057"},{"key":"e_1_3_2_15_2","first-page":"833","volume":"13","year":"1996","unstructured":"Cook, J. L., T. A. Potter, D. Bellgrau, and B. A. Routes. 1996. E1A oncogene expression in target cells induces cytolytic susceptibility at a post-recognition stage in the interaction with killer lymphocytes. Oncogene 13 : 833-842.","journal-title":"Oncogene"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.162082999"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1204900"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.271.47.30249"},{"key":"e_1_3_2_19_2","doi-asserted-by":"crossref","first-page":"4193","DOI":"10.4049\/jimmunol.143.12.4193","volume":"143","year":"1989","unstructured":"Duerksen-Hughes, P., W. S. Wold, and L. R. Gooding. 1989. Adenovirus E1A renders infected cells sensitive to cytolysis by tumor necrosis factor. J. Immunol. 143 : 4193-4200.","journal-title":"J. Immunol."},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.65.3.1236-1244.1991"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.17.10072"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1101\/gad.4.10.1823"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(00)80659-7"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.genet.31.1.177"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a120913"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a112394"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.76.11.5515-5521.2002"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.73.5.3623-3629.1999"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/15.20.8367"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.76.21.10608-10616.2002"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.7.2927"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.174.1.73"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.65.8.4114-4123.1991"},{"key":"e_1_3_2_34_2","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.4049\/jimmunol.145.9.3080","volume":"145","year":"1990","unstructured":"Gooding, L. R., I. O. Sofola, A. E. Tollefson, P. Duerksen-Hughes, and W. S. Wold. 1990. The adenovirus E3-14.7K protein is a general inhibitor of tumor necrosis factor-mediated cytolysis. J. Immunol. 145 : 3080-3086.","journal-title":"J. Immunol."},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1985.tb03687.x"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)80553-X"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/19.6.1243"},{"key":"e_1_3_2_38_2","unstructured":"Horwitz M. S. 1996. Adenoviruses p. 2149. In B. N. Fields D. M. Knipe P. M. Howley R. M Chanock J. L. Melnick T. P. Monath B. Roizman and S. E. Straus (ed.) Fields virology 3rd ed. vol. 2. Lippincott-Raven Publishers Philadelphia Pa."},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1101\/gad.1.10.1132"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)35846-0"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004419900155"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.18.1.621"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1038\/ni0302-221"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.2.987"},{"key":"e_1_3_2_45_2","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.4049\/jimmunol.162.5.2639","volume":"162","year":"1999","unstructured":"Kayagaki, N., N. Yamaguchi, M. Nakayama, A. Kawasaki, H. Akiba, K. Okumura, and H. Yagita. 1999. Involvement of TNF-related apoptosis-inducing ligand in human CD4+ T cell-mediated cytotoxicity. J. Immunol. 162 : 2639-2647.","journal-title":"J. Immunol."},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.165.4.1743"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1038\/35037728"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.14.6279"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/13.4.1209"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/0378-1119(88)90383-6"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.17.1.221"},{"key":"e_1_3_2_52_2","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.4049\/jimmunol.160.5.2374","volume":"160","year":"1998","unstructured":"Lewinsohn, D. M., T. T. Bement, J. Xu, D. H. Lynch, K. H. Grabstein, S. G. Reed, and M. R. Alderson. 1998. Human purified protein derivative-specific CD4+ T cells use both CD95-dependent and CD95-independent cytolytic mechanisms. J. Immunol. 160 : 2374-2379.","journal-title":"J. Immunol."},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.271.34.20392"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(00)80192-2"},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.1038\/370650a0"},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1204386"},{"key":"e_1_3_2_57_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1521-4141(199809)28:09<2714::AID-IMMU2714>3.0.CO;2-9"},{"key":"e_1_3_2_58_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.76.19.9716-9723.2002"},{"key":"e_1_3_2_59_2","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.21.16.5299-5305.2001"},{"key":"e_1_3_2_60_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.71.3.2004-2012.1997"},{"key":"e_1_3_2_61_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1994.tb06757.x"},{"key":"e_1_3_2_62_2","doi-asserted-by":"publisher","DOI":"10.1016\/0042-6822(83)90532-9"},{"key":"e_1_3_2_63_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.165.8.4522"},{"key":"e_1_3_2_64_2","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.16.8.4052"},{"key":"e_1_3_2_65_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.31.21495"},{"key":"e_1_3_2_66_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.70.1.68-77.1996"},{"key":"e_1_3_2_67_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.71.11.8299-8306.1997"},{"key":"e_1_3_2_68_2","doi-asserted-by":"publisher","DOI":"10.1128\/mcb.5.10.2684-2696.1985"},{"key":"e_1_3_2_69_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/24.13.2578"},{"key":"e_1_3_2_70_2","first-page":"135","volume":"232","year":"1998","unstructured":"Sparer, T. E., and L. R. Gooding. 1998. Suppression of MHC class I antigen presentation by human adenoviruses. Curr. Top. Microbiol. Immunol. 232 : 135-147.","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"e_1_3_2_71_2","first-page":"3957","volume":"60","year":"2000","unstructured":"Stiewe, T., K. Parssanedjad, H. Esche, B. Opalka, and B. M. Putzer. 2000. E1A overcomes the apoptosis block in BCR-ABL+ leukemia cells and renders cells susceptible to induction of apoptosis by chemotherapeutic agents. Cancer Res. 60 : 3957-3964.","journal-title":"Cancer Res."},{"key":"e_1_3_2_72_2","doi-asserted-by":"publisher","DOI":"10.1006\/excr.2001.5280"},{"key":"e_1_3_2_73_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.167.3.937"},{"key":"e_1_3_2_74_2","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.4049\/jimmunol.161.5.2195","volume":"161","year":"1998","unstructured":"Thomas, W. D., and P. Hersey. 1998. TNF-related apoptosis-inducing ligand (TRAIL) induces apoptosis in Fas ligand-resistant melanoma cells and mediates CD4 T cell killing of target cells. J. Immunol. 161 : 2195-2200.","journal-title":"J. Immunol."},{"key":"e_1_3_2_75_2","doi-asserted-by":"publisher","DOI":"10.1038\/33712"},{"key":"e_1_3_2_76_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.75.19.8875-8887.2001"},{"key":"e_1_3_2_77_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.88.15.6491"},{"key":"e_1_3_2_78_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/13.14.5389"},{"key":"e_1_3_2_79_2","doi-asserted-by":"publisher","DOI":"10.1128\/mcb.3.7.1222-1234.1983"},{"key":"e_1_3_2_80_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1990.tb07894.x"},{"key":"e_1_3_2_81_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.011283598"}],"container-title":["Journal of Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JVI.77.2.1112-1119.2003","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JVI.77.2.1112-1119.2003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T14:18:40Z","timestamp":1704723520000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JVI.77.2.1112-1119.2003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,1,15]]},"references-count":80,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2003,1,15]]}},"alternative-id":["10.1128\/JVI.77.2.1112-1119.2003"],"URL":"https:\/\/doi.org\/10.1128\/jvi.77.2.1112-1119.2003","relation":{},"ISSN":["0022-538X","1098-5514"],"issn-type":[{"value":"0022-538X","type":"print"},{"value":"1098-5514","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,1,15]]},"assertion":[{"value":"2002-07-31","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2002-10-03","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2003-01-15","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}